Explicyte is a family brand of specialty preclinical services launched by ImmuSmol, a bordeaux-based company. The first brand, Explicyte Immune-Oncology offers preclinical contract research services in immuno-oncology. Explicyte Immuno-Oncology currently offers to test innovative cancer immunotherapies in vivo, using syngeneic mouse tumor models treated with immune checkpoint inhibitors (eg. anti-CTLA-4 and anti-PD1/PD-L1 antibodies). In addition, Explicyte is setting up an in vitro platform for the identification and optimization of novel immunomodulators. Equipped with high-content analysis technologies, the platform focuses on live phenotypic screening in co-cultures of immune and cancer cells, as well as molecular cell-based assays for the assessment of immune checkpoint inhibitors.
View Top Employees from ExplicyteWebsite | http://www.explicyte.com |
Employees | 12 (12 on RocketReach) |
Address | 229 Cours de l'Argonne, Bordeaux, Nouvelle-Aquitaine 33000, FR |
Technologies |
JavaScript,
HTML,
Twitter
+9 more
(view full list)
|
Industry | Biotechnology Research, Preclinical research services, CRO, In vitro and In vivo, Service provider, Oncology, Immuno-Oncology |
Looking for a particular Explicyte employee's phone or email?
Loic Cerf is the COO of Explicyte.
12 people are employed at Explicyte.
Explicyte is based in Bordeaux, Nouvelle-Aquitaine.